Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10927160
Engineered invariant natural killer T (iNKT) cells and methods of making and using thereof
granted -
US 10927349
Platform for generating safe cell therapeutics
granted -
US 10925972
Glycan-dependent immunotherapeutic molecules
granted -
US 10925975
Acidic nanoparticles for restoration of autophagy
granted -
US 10927165
Antibodies that neutralize botulinum neurotoxins
granted -
US 10918594
Controlled-release CNS modulating compositions and methods for the treatment of otic disorders
granted -
US 10920190
Folding biological tissue via programmed cellular contractility
granted -
US 10918738
Method of treating type I diabetes using an AAV vector encoding uracortin 2
granted -
US 10919932
Bi-terminal pegylated integrin-binding peptides and methods of use thereof
granted -
US 10918598
On demand vesicle formation from vesicle precursors suitable for long-term storage
granted -
US 10918653
Bovine milk oligosaccharides
granted -
US 10918648
Estrogen receptor modulator combinations
granted -
US 10918703
Fusion proteins for treating inflammatory diseases
granted -
US 10913957
Genetically modified MSC and therapeutic methods
granted -
US 10912933
Implants for localized drug delivery and methods of use thereof
granted -
US 10912834
Topical formulations based on ionic species for skin treatment
granted -
US 10913798
Modulators of ROR1-ROR2 binding
granted -
US 10913726
Centrally active and orally bioavailable antidotes for organophosphate exposure and methods for making and using them
granted -
US 10912860
Controllable self-annealing microgel particles for biomedical applications
granted -
US 10912764
Salinosporamides and methods of use thereof
granted -
US 10913750
Tubulin-binding compounds, compositions and uses related thereto
granted -
US 10905736
Ezetimibe-associated ApoA-I mimetic peptides showing enhanced synergism
granted -
US 10907124
Biomimetic membranes, methods of manufacture and uses thereof
granted -
US 10900054
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted